Ignite Creation Date:
2025-12-25 @ 3:13 AM
Ignite Modification Date:
2026-01-23 @ 6:59 AM
Study NCT ID:
NCT01844505
Status:
COMPLETED
Last Update Posted:
2025-05-21
First Post:
2013-04-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-06-11
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-19
Completion Date Type:
ACTUAL
First Submit Date:
2013-04-29
First Submit QC Date:
None
Study First Post Date:
2013-05-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-07-14
Results First Submit QC Date:
None
Results First Post Date:
2017-09-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-05
Last Update Post Date:
2025-05-21
Last Update Post Date Type:
ACTUAL